|
Report Alleges Medtronic Paid Doctors to Minimize Risks of InFuse Bone Graft
A 16-month Senate Finance Committee investigation of Medtronic revealed dubious ties with researchers and behind-the-scenes efforts to ensure medical journals portrayed the company’s InFuse bone graft favorably, according to a report released Wednesday.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives